Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Cyclacel Pharmaceuticals, Inc. (CYCC)

Income Statement Business | Geographic

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues   [+]0.00.00.00.00.20.00.81.7
            Revenue growth     -100.0% -100.0%-50.2%-2.3%
Cost of goods sold  27.722.910.69.79.70.015.018.1
Gross profit  -27.7-22.9-10.6-9.7-9.50.0-14.2-16.4
            Gross margin      -6365.3% -1678.5%-969.3%
Selling, general and administrative       9.5  
Research and development          
Other operating expenses  -0.4-0.1-0.1-0.3-0.2-0.1-0.30.2
EBITDA   [+]-27.2-22.8-10.6-9.3-9.3-9.4-13.7-16.4
            EBITDA margin      -6185.3% -1626.0%-966.4%
Depreciation and amortization  0.00.00.00.00.00.00.10.2
EBIT   [+]-27.2-22.9-10.6-9.4-9.3-9.4-13.8-16.6
            EBIT margin      -6204.7% -1641.8%-978.7%
Interest income  0.20.00.00.20.30.10.00.0
Other income (expense), net   [+]1.10.10.80.00.40.80.00.1
Pre-tax income  -25.9-22.7-9.7-9.1-8.6-8.5-13.8-16.5
Income taxes  -4.7-3.8-1.2-1.3-1.3-1.0-2.0-2.1
            Tax rate  18.2%16.9%12.8%14.2%15.5%11.7%14.4%13.0%
Net income  -21.2-18.9-8.4-7.8-7.3-7.5-11.8-14.3
            Net margin      -4858.7% -1398.7%-846.6%
   
Basic EPS   [+]($1.88)($2.12)($2.32)($9.59)($0.60)($1.96)($3.44)($5.29)
Diluted EPS   [+]($1.88)($2.12)($2.32)($9.59)($0.60)($0.98)($3.44)($5.29)
   
Shares outstanding (basic)   [+]11.38.93.60.812.13.83.42.7
Shares outstanding (diluted)   [+]11.38.93.60.812.17.63.42.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy